Is on the beach a buy?
On the Beach Group has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Is aware a good stock to buy?
Consensus Rating. Aware has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
How do I look up the price of a stock?
The 10 Best Ways to Check Stock Prices OnlineMarketWatch.CNN Markets.U.S News.Google Finance.Investopedia.6. Yahoo! Finance.Stocks (Mac)Nasdaq.More items...•
What is the best stock to buy right now?
Top 10 Stocks To Buy Right NowApple Inc. (NASDAQ: AAPL)Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL)Palo Alto Networks, Inc. (NASDAQ: PANW)Shopify Inc. (NYSE: SHOP)Advanced Micro Devices, Inc. (NASDAQ: AMD)Netflix, Inc. (NASDAQ: NFLX)The Walt Disney Company (NYSE: DIS)CrowdStrike Holdings, Inc. (NASDAQ: CRWD)More items...•
Is Amazon going to have a stock split?
Amazon Announces 20-1 Stock Split Amazon approved a 20-1 stock split and a $10 billion stock buyback on March 9. The board said the split would “give our employees more flexibility in how they manage their equity in Amazon and make the share price more accessible for people looking to invest.”
Where should I invest right now?
12 best investmentsHigh-yield savings accounts.Certificates of deposit (CDs)Money market funds.Government bonds.Corporate bonds.Mutual funds.Index funds.Exchange-traded funds (ETFs)More items...
Is DIAGNOS a buy right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last twelve months. There are currently 1 buy rating for th...
When is DIAGNOS's next earnings date?
DIAGNOS is scheduled to release its next quarterly earnings announcement on Tuesday, June 14th 2022. View our earnings forecast for DIAGNOS .
How were DIAGNOS's earnings last quarter?
DIAGNOS Inc. (CVE:ADK) released its quarterly earnings results on Monday, February, 28th. The company reported ($0.01) earnings per share (EPS) for...
Who are DIAGNOS's key executives?
DIAGNOS's management team includes the following people: Mr. Andre Larente , CEO, Pres & Exec. Director Mr. Marc-André Massue , VP of Fin., CFO...
Who are some of DIAGNOS's key competitors?
Some companies that are related to DIAGNOS include Induction Healthcare Group (INHC) , Trellus Health (TRLS) , IQ-AI (IQAI) , CardioComm Soluti...
What other stocks do shareholders of DIAGNOS own?
Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America...
What is DIAGNOS's stock symbol?
DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."
How do I buy shares of DIAGNOS?
Shares of ADK and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...
What is DIAGNOS's stock price today?
One share of ADK stock can currently be purchased for approximately C$0.17.
Is DIAGNOS a buy right now?
How has DIAGNOS's stock been impacted by Coronavirus?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DIAGNOS stock. View analyst ratings for DIAGNOS or view top-rated stocks.
When is DIAGNOS's next earnings date?
DIAGNOS's stock was trading at C$0.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ADK shares have increased by 31.8% and is now trading at C$0.29. View which stocks have been most impacted by COVID-19.
Who are some of DIAGNOS's key competitors?
DIAGNOS is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022. View our earnings forecast for DIAGNOS.
What other stocks do shareholders of DIAGNOS own?
Some companies that are related to DIAGNOS include Induction Healthcare Group (INHC), Sensyne Health (SENS), IQ-AI (IQAI), CardioComm Solutions (EKG), ZoomMed (ZMD), 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), Carebook Technologies (CRBKF), CloudMD Software & Services (DOCRF), Cogstate (CGS), Corum Group (COO), EGF Theramed Health (EVAHF) and Emyria (EMD). View all of ADK's competitors..
What is DIAGNOS's stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).
How do I buy shares of DIAGNOS?
DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."
DIAGNOS Provides Corporate Update for 2021 and Outlook for 2022
Shares of ADK and other Canadian stocks can be purchased through an online brokerage account.
DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022
BROSSARD, Quebec, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues based on Artificial Intelligence, is pleased to provide a corporate update on its major activities from 2021 operations.
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE
BROSSARD, Quebec, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today that DIAGNOS will be in San Francisco during the J.P.
DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA
BROSSARD, Quebec, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc.
Diagnos Inc.: Using Artificial Intelligence to Analyze the Retina, CEO Clip Video
BROSSARD, Quebec, Oct. 28, 2021 (GLOBE NEWSWIRE) -- DIAGNOS Inc.
DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel
Vancouver, British Columbia-- (Newsfile Corp. - September 24, 2021) - Diagnos Inc. (TSXV: ADK) - CEO, André Larente, speaks about their product 'Cara,' used for computer-assisted retinal analysis.If you cannot view the video above, please visit:https://b-tv.com/diagnos-using-ai-to-analyze-the-retina/.Diagnos Inc. (TSXV: ADK) Diagnos Inc.
DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster
BROSSARD, Quebec, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces it will be featured on CEO Clips on the BNN Bloomberg Channel on September 25th and 26th, 2021.
